Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial
RCT (n=352) found no significant difference in the primary composite end point of mortality, persistent bacteremia, relapse, or treatment failure for addition of an antistaphylococcal β-lactam to standard antibiotic therapy (vancomycin or daptomycin) vs standard therapy alone. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 13, 2020 Category: Consumer Health News Source Type: news

Drug Combo No Better in MRSA Blood Infections, Ups Risk Drug Combo No Better in MRSA Blood Infections, Ups Risk
Adding a beta-lactam to standard therapy for MRSA bacteremia does not improve outcomes and appears to up the risk for kidney injury, data from a randomized controlled trial showed.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - February 11, 2020 Category: Internal Medicine Tags: Infectious Diseases News Source Type: news

Trial shows using two drugs not better than one when treating MRSA blood infections
(University of Melbourne) Researchers attempting to improve the treatment for methicillin-resistant Staphylococcus aureus (MRSA) blood infections have discovered the combination of two antibiotics was no better than one, and led to more adverse effects. In what is the biggest trial of MRSA bloodstream infections to date, (352 participants from Australia, Singapore, New Zealand and Israel), the CAMERA2 clinical trial, researchers were surprised to see the drug combination wasn't as effective as anticipated. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 11, 2020 Category: Infectious Diseases Source Type: news

The Coronavirus Outbreak Should Bring Out the Best in Humanity
Pandemics are perversely democratic. They’re nasty, lethal and sneaky, but they don’t discriminate. No matter your age, ethnicity, religion, gender, or nation, you’re a part of the pathogenic constituency. That shared vulnerability, and the resulting human collectivism—a universal response to a universal threat—is newly and vividly evident in the face of the now-global outbreak of the novel coronavirus known as 2019-nCoV. As of writing, there have been over 30,000 diagnosed cases and over 630 related deaths. A virus that emerged in a single city, Wuhan, China—indeed, in a single crowded ...
Source: TIME: Health - February 8, 2020 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized 2019-nCoV Infectious Disease Source Type: news

FDA Tells Purell Maker to Stop Making False Claims
The agency warned Gojo Industries that unsubstantiated claims that Purell can help prevent illnesses such as the flu, Ebola virus, norovirus and the MRSA superbug violate federal laws, The New York Times reported Tuesday. (Source: WebMD Health)
Source: WebMD Health - January 29, 2020 Category: Consumer Health News Source Type: news

F.D.A. Warns Purell to Stop Claiming It Can Prevent Ebola or Flu
The Food and Drug Administration told the maker of Purell hand sanitizers to discontinue marketing campaigns that the agency complained also included claims for avoiding illness from other viruses. (Source: NYT Health)
Source: NYT Health - January 29, 2020 Category: Consumer Health News Authors: Sheila Kaplan Tags: Purell Drugs (Pharmaceuticals) Cleansers, Detergents and Soaps Methicillin-Resistant Staphylococcus Aureus Influenza Norovirus Ebola Virus Gojo Industries Inc Food and Drug Administration Hygiene and Cleanliness your-feed-healthcare Source Type: news

FDA Warns Purell To Stop Making Unproven Claims About Hand Sanitizers
(CNN) — The US Food and Drug Administration is giving the maker of Purell products a stern warning: Stop making unproven claims that over-the-counter hand sanitizers help eliminate Ebola, MRSA or the flu. In a “warning letter” to Purell’s parent, Gojo Industries, the agency called out the company for making numerous marketing claims that potentially position its sanitizing products as a pharmaceutical drug rather than an over-the-counter topical antiseptic. The letter from the agency’s director of compliance cited numerous examples of what the FDA says are unproven claims for Purell products m...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 27, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston CNN Hand Sanitizer Source Type: news

Nasal and Skin Decolonization Safely Replaces Contact Precautions for MRSA-Colonized Patients Nasal and Skin Decolonization Safely Replaces Contact Precautions for MRSA-Colonized Patients
Nasal and skin decolonization safely and less expensively replaced contact precautions for patients colonized with methicillin-resistant Staphylococcus aureus (MRSA) at one U.S. hospital network, according to a new report.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 27, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

UK still free of coronavirus cases
Patients with symptoms advised to call GP rather than attend practice Related items fromOnMedica Warn patients that natural malaria immunity fades Single-dose malaria drug eliminates parasite from liver Should we have compulsory measles vaccination at school entry? Parents still following folklore methods for cold prevention Double check patients with ‘penicillin’ allergy to avoid MRSA risk (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 27, 2020 Category: UK Health Source Type: news

Lack of antibiotics in low income countries 'worsening  superbugs threat'
Only three new treatments available in 10 or more poorer countries, report findsMany antibiotics are unavailable in poorer countries despite higher infection rates, exacerbating the threat of drug-resistant superbugs, according to a report to bepresented to world leaders and the bosses of top pharmaceutical companies in Davos.The report, released by the Access to Medicine Foundation, an Amsterdam-based non-profit group, also shows that the number of new treatments being developed for common infectious diseases such as pneumonia, tuberculosis and gonorrhoea has fallen.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 21, 2020 Category: Science Authors: Julia Kollewe Tags: Antibiotics Business Davos 2020 Drugs MRSA and superbugs Health Source Type: news

Cannabis compound could be weapon in fight against superbugs
Mice cured of MRSA, raising hopes of treating antibiotic-resistant bacteriaA compound made by cannabis plants has been found to wipe out drug-resistant bacteria, raising hopes of a new weapon in the fight against superbugs.Scientists screened five cannabis compounds for their antibiotic properties and found that one, cannabigerol (CBG), was particularly potent at killing methicillin-resistant Staphylococcus aureus (MRSA), one of the most common hospital superbugs.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 19, 2020 Category: Science Authors: Ian Sample Science editor Tags: Drug resistance Antibiotics Medical research Cannabis Science UK news Source Type: news

Wockhardt gets DGCI approval for 2 new antibiotics
"DCGI (Drug Controller General of India) has approved Wockhardt's two new antibiotics, EMROK (IV) and EMROK 0 (Oral), for acute bacterial skin and skin structure infections including diabetic foot infections and concurrent bacteraemia...," the drug firm said. The new drug will target superbug like Methicillin resistant Staphylococcus aureus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 16, 2020 Category: Pharmaceuticals Source Type: news

NHS declares victory on MRSA and takes fight to E coli
Trusts and clinical commissioning groups face new annual targets designed to combat rising levels of four bloodstream infections, but sanctions relating to MRSA and C difficile could be scrapped. (Source: HSJ)
Source: HSJ - January 10, 2020 Category: UK Health Source Type: news

New Strategies to Prevent MRSA Infections in Your Hospital New Strategies to Prevent MRSA Infections in Your Hospital
A community hospital's rate of MRSA bloodstream infections is much higher than the national rate. Would you know what to do to reverse this trend?CDC Expert Commentary (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - December 23, 2019 Category: Infectious Diseases Tags: Infectious Diseases Case Challenge Source Type: news

It takes “2 weeks to build up immunity” to the flu after the vaccine is administered, claims the industry that has paid out over $2 billion for flu shot injuries
(Natural News) Nurses and doctors across America will beg and plead with you to get your flu shot “early” so you can build up immunity to the known mass serial killer called influenza. Yet, most people who die from the flu didn’t really. They died from pneumonia, MRSA superbugs and a crippled immune system caused... (Source: NaturalNews.com)
Source: NaturalNews.com - December 22, 2019 Category: Consumer Health News Source Type: news

The new polymer can kill drug-resistant bacteria
Researchers from Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, and Nanyang Technological University (NTU) have designed an antimicrobial polymer that can kill bacteria resistant to commonly used antibiotics, including the superbug Methicillin-resistant Staphylococcus aureus (MRSA). (Source: World Pharma News)
Source: World Pharma News - December 12, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

FDA Clears Faster Diagnostic Test for MRSA
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 6, 2019 Category: General Medicine Source Type: news

FDA Clears Faster Diagnostic Test for MRSA FDA Clears Faster Diagnostic Test for MRSA
The cobas vivoDx MRSA test uses a new bacteriophage technology based on bioluminescence to detect MRSA from nasal swab samples in 5 hours or less compared with 24 to 48 hours for conventional cultures.FDA Approvals (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - December 6, 2019 Category: Emergency Medicine Tags: Infectious Diseases News Alert Source Type: news

Survey finds high level of self-prescribing among doctors
Young doctors also prescribing to friends and family Related items fromOnMedica GPs need more time to treat complex needs GPs defend practice on prescribing statins Double check patients with ‘penicillin’ allergy to avoid MRSA risk Clinicians need better options if we are to stop over-medication MHRA tightens licence restrictions on valproate for women (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 4, 2019 Category: UK Health Source Type: news

MRSA Spreads Easily in Households MRSA Spreads Easily in Households
Methicillin-resistant Staphylococcus aureus (MRSA) can spread easily from people to household pets, according to a new study that underscores the importance of frequent handwashing.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - November 28, 2019 Category: Pathology Tags: Infectious Diseases News Source Type: news

Longitudinal, strain-specific Staphylococcus aureus introduction and transmission events in households of children with community-associated meticillin-resistant S aureus skin and soft tissue infection: a prospective cohort study
Review of 150 children with community-associated MRSA (caMRSA) skin and soft tissue infections found that sharing bedrooms, sharing bath towels and living in homes with a higher environmental contamination burden increased the likelihood of spread of caMRSA. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 28, 2019 Category: Consumer Health News Source Type: news

Household Environment Plays Role in MRSA Acquisition
WEDNESDAY, Nov. 27, 2019 -- The household environment plays a key role in the acquisition of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infection, according to a study published online Nov. 26 in The Lancet Infectious... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 27, 2019 Category: Pharmaceuticals Source Type: news

Drug-resistant staph spreads easily in households
(Reuters Health) - The superbug MRSA (methicillin-resistant Staphylococcus aureus) can spread easily from people to household pets, according to a new study that underscores the importance of frequent handwashing. (Source: Reuters: Health)
Source: Reuters: Health - November 27, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

This New Compound May Be Able To Battle A Common Hospital Superbug
Researchers in Canada have identified a new compound which makes superbug MRSA susceptible to treatment with common antibiotics again. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 26, 2019 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

Potent antimicrobial found that shows promise in fighting staph infections
(McMaster University) After screening thousands of small molecules, the research team discovered a potent new antimicrobial they are calling MAC-545496 that is active against MRSA. Unlike conventional antibiotics, this new antimicrobial neither kills the staph infection nor halts its growth on its own, so the potential for antimicrobial resistance may be considerably lessened. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 25, 2019 Category: Infectious Diseases Source Type: news

Drug-resistant staph can spread easily in household environments
(Washington University in St. Louis) Once rare, the superbug methicillin-resistant Staphylococcus aureus (MRSA) infects hundreds of thousands of people in the US each year and kills about 20,000. New research led by Washington University School of Medicine in St. Louis sheds light on how MRSA is introduced into households and, once there, how it can spread among family members, including the furry ones. Understanding MRSA's transmission dynamics is critical to devising effective preventive tactics. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 21, 2019 Category: Infectious Diseases Source Type: news

A Tiny Bug Ended My NFL Career —and Almost My Life
During my nine years in the NFL, I ruptured tendons in my fingers, suffered multiple concussions, and broke several bones. I tore my ACL, MCL, and PCL, and completely blew out my left knee. That last injury should have ended my career. But it didn’t. I put myself back together and played through the pain. What finally took me down? A tiny bug I had never heard of and couldn’t see. A drug-resistant staph infection called methicillin-resistant Staphylococcus aureus cost me my NFL career—and almost my life. MRSA is one of many deadly, antibiotic-resistant infections. Together, these “superbugs” k...
Source: TIME: Health - November 19, 2019 Category: Consumer Health News Authors: Brandon Noble Tags: Uncategorized health Source Type: news

Nearly half of older adults think they ’ll get dementia
But few discuss prevention with their physician Related items fromOnMedica Experts urge radical action on mental health crises Double check patients with ‘penicillin’ allergy to avoid MRSA risk Social prescribing workers to ease GP pressure Scotland launches its ‘Detect Cancer Early’ campaign Midwives demand ‘equivalence’ in prison perinatal care (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 18, 2019 Category: UK Health Source Type: news

Scientists discover how potent bacterial toxin kills MRSA bacteria
(University of Sheffield) Scientists from the University of Sheffield have discovered how a potent bacterial toxin is able to target and kill MRSA, paving the way for potential new treatments for superbugs. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 4, 2019 Category: Infectious Diseases Source Type: news

Test can tell whether bacteria is resistant to antibiotics in less than 45 minutes
The new method, developed by experts at the University of Strathclyde in Scotland, was tested on staphylococcus aureus and MRSA. (Source: the Mail online | Health)
Source: the Mail online | Health - October 24, 2019 Category: Consumer Health News Source Type: news

Genetic mutation may help people fight off deadly MRSA infections
Scientists from Duke University analysed 68 people, half of which had a persistent MRSA infection, while the remaining 34 participants managed to clear the bacteria from their bloodstream. (Source: the Mail online | Health)
Source: the Mail online | Health - September 17, 2019 Category: Consumer Health News Source Type: news

Infection prevention control and organisational patient safety culture within the context of isolation: study protocol
Healthcare associated infection (HCAI) is a major cause of morbidity and mortality. In recent years, there have been high profile successes in infection prevention control (IPC), such as the dramatic reductions in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (which is viewed as one proxy indicator of overall harm) and Clostridium difficile in the UK. Nevertheless, HCAI remains a costly burden to health services, a source of concern to patients and the public and at present, is receiving priority from policy makers as it contributes to the global threat of antimicrobial resistance. (Source: Curr...
Source: Current Awareness Service for Health (CASH) - September 12, 2019 Category: Consumer Health News Source Type: news

Medical News Today: Antibiotic resistance can spread in the absence of drugs
Using mice, scientists have recently identified a mechanism independent of antibiotic use that can spread drug resistance among intestinal bacteria. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 9, 2019 Category: Consumer Health News Tags: MRSA / Drug Resistance Source Type: news

GPs should avoid antibiotics for non-bullous impetigo
NICE proposes use of antiseptic creams instead Related items fromOnMedica Single-dose malaria drug eliminates parasite from liver Patients often avoid vaccinations due to fear of side effects Double check patients with ‘penicillin’ allergy to avoid MRSA risk Ibuprofen not a safe alternative to antibiotics for uncomplicated UTIs Inhaled corticosteroids linked to higher infection risk (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 15, 2019 Category: UK Health Source Type: news

Medical News Today: Cigarette smoke increases superbug's antibiotic resistance
Scientists have exposed bacterial strains to cigarette smoke in the laboratory and found that the smoke increased the bacteria's resistance to antibiotics. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 1, 2019 Category: Consumer Health News Tags: MRSA / Drug Resistance Source Type: news

Cigarette smoke makes MRSA more resistant to antibiotics
University of Bath experts exposed six different strains of MRSA - as well as other strains of S aureus - in the lab to tobacco smoke. The findings were published in Scientific Reports. (Source: the Mail online | Health)
Source: the Mail online | Health - July 31, 2019 Category: Consumer Health News Source Type: news

Patients to be offered same-day pharmacy consultations
Scheme could ease pressure on GPs Related items fromOnMedica Double check patients with ‘penicillin’ allergy to avoid MRSA risk Review launched into prescription drug dependency Promise to end new HIV transmissions in England by 2030 Criminal sanctions fail to curb illegal drug use Educate teens about cannabis mental health risks (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 23, 2019 Category: UK Health Source Type: news

Fighting HAIs with AI
Healthcare-associated infections (HAIs) continue to be an ongoing threat to patients. “Despite the best care, patients get infections,” Brian Gross, business lead, genomics for infectious disease at Philips, told MD+DI. Because they are “technically avoidable, there’s pressure on hospitals to drive their numbers down.” Healthcare system professionals have struggled with two main problems when trying to identify and act on infection risks, Gross explained. “The problem is two-fold. First, because of current tools, all...
Source: MDDI - July 17, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Software Source Type: news

Immune system effectiveness appears key to antibiotic success against persistent bacteria
(PLOS) Mathematical modeling suggests that the rate at which a patient's immune system clears slow-growing variants of methicillin-resistant Staphylococcus aureus (MRSA) bacteria is a key determinant of whether antibiotics can cure the infection. Tsuyoshi Mikkaichi and Alexander Hoffmann of the University of California, Los Angeles, and the MRSA Systems Immunobiology Group present this work in PLOS Computational Biology. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 11, 2019 Category: Infectious Diseases Source Type: news

Fighting drug resistance with fast, artificial enhancement of natural products
(University of Tokyo) Japanese researchers have identified multiple promising new drug candidates to treat antibiotic-resistant infections, including superbugs. The team developed a new technique to enhance the infection-fighting potential of natural chemicals and test them quickly. In laboratory tests, three of the synthetic molecules that the researchers built are four times more effective at killing bacteria than their natural predecessor, which is itself already an order of magnitude more potent than the current drug used against MRSA, vancomycin. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 8, 2019 Category: Infectious Diseases Source Type: news

Bacterial and Fungal Infections in Persons Who Inject Drugs --- Western New York, 2017
During 2014--2017, CDC Emerging Infections Program surveillance data reported that the occurrence of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections associated with injection drug use doubled among persons aged 18--49 years residing in Monroe County in western New York. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 3, 2019 Category: American Health Tags: Infection MMWR Morbidity & Mortality Weekly Report Staphylococcus aureus (Staph) Source Type: news

6 NICU newborns and 6 staff members contract antibiotic-resistant MRSA at Pennsylvania hospital
Six NICU newborns and six workers have tested positive for MRSA, an antibiotic-resistant superbug, at UPMC Children's Hospital of Pittsburgh in Pennsylvania. (Source: the Mail online | Health)
Source: the Mail online | Health - July 2, 2019 Category: Consumer Health News Source Type: news

UPMC reports a dozen cases of MRSA at Children's Hospital
Six patients and six staff members at UPMC Children's Hospital of Pittsburgh have tested positive for MRSA, UPMC said Monday. The cases were confirmed at UPMC Children's neonatal intensive care unit (NICU). The hospital said all patients in the NICU were tested, with six testing positive. One of those six was potentially symptomatic with MRSA, also known as methicillin-resistant Staphylococcus aureus. Several staff me mbers were tested with potential symptoms, and six were confirmed to have MRSA… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 1, 2019 Category: Pharmaceuticals Authors: Ethan Lott Source Type: news

UPMC reports a dozen cases of MRSA at Children's Hospital
Six patients and six staff members at UPMC Children's Hospital of Pittsburgh have tested positive for MRSA, UPMC said Monday. The cases were confirmed at UPMC Children's neonatal intensive care unit (NICU). The hospital said all patients in the NICU were tested, with six testing positive. One of those six was potentially symptomatic with MRSA, also known as methicillin-resistant Staphylococcus aureus. Several staff me mbers were tested with potential symptoms, and six were confirmed to have MRSA… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 1, 2019 Category: Biotechnology Authors: Ethan Lott Source Type: news

Nurses celebrate 600 days MRSA free at hospital trust
Nursing staff at a hospital trust in Yorkshire are celebrating 600 days without a single case of the superbug MRSA. (Source: Nursing Times)
Source: Nursing Times - June 27, 2019 Category: Nursing Source Type: news

Superbug MRSA susceptible to existing antibiotics
Methicillin-resistantStaphylococcus aureus (MRSA) has become a serious problem, forcing doctors to turn to antibiotics other than penicillin or penicillin derivatives, or to different drug cocktails, which are often less effective in treating hospital and community based infections. (Source: Medical Research Council General News)
Source: Medical Research Council General News - June 25, 2019 Category: Research Source Type: news

Widely available antibiotics could be used in the treatment of 'superbug' MRSA
(University of Cambridge) Some MRSA infections could be tackled using widely-available antibiotics, suggests new research from an international collaboration led by scientists at the University of Cambridge and the Wellcome Sanger Institute. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2019 Category: Infectious Diseases Source Type: news

What Infectious Diseases are Important to Consider in Transplantation Patients?
Discussion Transplantation is not a common problem for primary care physicians but when a child’s disease has progressed to end-stage organ failure, transplantation can be the only treatment available. While the primary care provider usually is not involved in the daily management of patients before, during and after transplantation, they can be involved in many areas. These can include providing appropriate primary and acute care, ordering and obtaining necessary medical tests, medications and equipment, assisting with medical insurance, providing medical history and records to consultants, translating medical infor...
Source: PediatricEducation.org - June 24, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Ticagrelor: A New Antibiotic?
The antiplatelet agent ticagrelor (Brilinta/Brilique, AstraZeneca) demonstrated bactericidal activity against antibiotic-resistant gram-positive bacteria that pose a threat to human health, including methicillin-resistant Staphylococcus aureus (MRSA), and may represent a new class of antibiotic active against multidrug-resistant staphylococci or enterococci, new research suggests. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 7, 2019 Category: Consumer Health News Source Type: news

Employers should help boost staff physical activity
GPs back NICE physical activity advice Related items fromOnMedica Double check patients with ‘penicillin’ allergy to avoid MRSA risk Safeguarding: what lies ahead for 2019 Stop smoking aids — better than going 'cold turkey' Weight loss targets exceeded on NHS type 2 diabetes prevention programme More global deaths from poor diet than from smoking (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 6, 2019 Category: UK Health Source Type: news